https://www.selleckchem.com/pr....oducts/sbi-0206965.h
The purpose of the meeting was to develop international expert consensus recommendations on the use of such tumour-agnostic treatments in patients with solid tumours. The aim was to generate a reference document for clinical practice, for pharmaceutical companies in the design of clinical trials, for ethics committees in the approval of clinical trial protocols and for regulatory authorities in relation to drug approvals, with a particular emphasis on diagnostic testing and patient selection. BACKGROUND Aspirin has been associated w
Curtir
Comentario
Compartilhar
